12:00 AM
 | 
Mar 05, 2012
 |  BC Week In Review  |  Company News  |  Other News

Sequenom, Verinata diagnostic news

Verinata said it filed suit against Sequenom in the U.S. District Court for the Northern District of California seeking declaratory judgment that Verinata's cell-free DNA sequencing analysis techniques used in its verifi prenatal test do not infringe Sequenom's U.S. Patent No. 6,258,540. The patent covers prenatal diagnosis using nucleic acid analysis used in Sequenom's MaterniT21 Plus laboratory-developed test (LDT) to detect fetal trisomies 13, 18...

Read the full 321 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >